| CTRI Number |
CTRI/2026/01/102558 [Registered on: 30/01/2026] Trial Registered Prospectively |
| Last Modified On: |
29/01/2026 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Observational |
|
Type of Study
|
Cross Sectional Study |
| Study Design |
Other |
|
Public Title of Study
|
A Study To Evaluate Cognitive Functions In cancer Patients With Non-Brain Cancers Receiving Chemotherapy help with fact-cog questionnaire |
|
Scientific Title of Study
|
Assessment of Cognitive Functions In Non-Central Nervous System Cancer Patients Undergoing Chemotherapy- A Coss Sectional Study |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dhruvi Manojbhai Prajapati |
| Designation |
1st year Post Graduate student |
| Affiliation |
Sumandeep Vidyapeeth |
| Address |
PG 1 Classroom 2nd Floor, Department Of Neurological and psychosomatic disorders, college of Physiotherapy, Deemed to be University at and post ,Pipariya ,Taluka
Waghodia
Vadodara GUJARAT 391760 India |
| Phone |
09714806834 |
| Fax |
|
| Email |
dhruviprajapati091@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Dhwani Chanpura |
| Designation |
Professor |
| Affiliation |
Sumandeep Vidyapeeth |
| Address |
Staffroom Ground floor, Department of Neurological and psychosomatic disorders, college of Physiotherapy, Deemed to be University at and post piparia ,taluka Waghodia
Vadodara GUJARAT 391760 India |
| Phone |
9974704464 |
| Fax |
|
| Email |
dhwani.cop@sumandeepvidyapeeth.edu.in |
|
Details of Contact Person Public Query
|
| Name |
Dr Dhwani Chanpura |
| Designation |
Professor |
| Affiliation |
Sumandeep Vidyapeeth |
| Address |
Staffroom Ground floor, Department of Neurological and psychosomatic disorders, college of Physiotherapy, Deemed to be University at and post piparia ,taluka Waghodia
Vadodara GUJARAT 391760 India |
| Phone |
9974704464 |
| Fax |
|
| Email |
dhwani.cop@sumandeepvidyapeeth.edu.in |
|
|
Source of Monetary or Material Support
|
| Dhiraj General Hospital ,Waghodia road, Vadodara, Gujarat, India 391760 |
|
|
Primary Sponsor
|
| Name |
Dhruvi Prajapati |
| Address |
College of Physiotherapy ,Sumandeep Vidyapeeth Deemed to be University ,Piparia, Waghodia ,Vadodara 391760 |
| Type of Sponsor |
Other [[Self funded]] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dhruvi Prajapati |
Dhiraj General Hospital |
Oncology Department,4th floor Dhiraj General Hospital, Waghodia road, Vadodara,Gujarat 391760 Vadodara GUJARAT |
9714806834
dhruviprajapati091@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Sumandeep Vidyapeeth Institutional Ethics Committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: C00-D49||Neoplasms, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Nil |
Nil |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
Diagnosed with any non-central nervous system cancer.
Currently receiving 1st cycle of chemotherapy and onwards.
Willing to provide informed consent.
|
|
| ExclusionCriteria |
| Details |
Previous history of neurological disorders and diagnosed with psychiatric illnesses.
Patients with uncontrolled systemic diseases.
Patients with sensory deficits.
Patient undergoing concurrent radiotherapy treatment.
|
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Functional Assessment of Cancer Therapy- Cognitive Functional Questionnaire |
Outcome Measure will be taken at baseline. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Functional Cancer Therapy-Cognitive Functional Questionnaire |
it will be taken from baseline |
|
|
Target Sample Size
|
Total Sample Size="61" Sample Size from India="61"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
09/02/2026 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
This study aims to assess cognitive functions in non-central nervous system cancer patients receiving chemotherapy using the Functional Assessment of Cancer Therapy–Cognitive Function (FACT-Cog) questionnaire. The study will help identify chemotherapy-related cognitive changes and support early intervention to improve patient quality of life. Patients will be recruited from the oncology department. Only Eligible
individuals will be screened, based on the inclusion and exclusion criteria. After
explaining the study purpose and whole procedure of study, informed consent
form will be given. The patient will be informed that the
questionnaire assessed perceived cognitive function, not intelligence. They will
be instructed to respond based on their experiences during the past 7 days.
Clarification will be provided that there are no right or wrong answers. The
FACT-Cog questionnaire is administered in self-reported format. If the
patient has difficulty reading or understanding, the questionnaire will be
interviewer-assisted, without influencing responses. |